| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 64, 1-9, Copyright © 1987 by Endocrine Society
ARTICLES |
H Reichel, HP Koeffler, JE Bishop and AW Norman
Cultured normal human pulmonary alveolar macrophages and peripheral blood monocyte-derived macrophages were studied for their capacity to metabolize [3H]25-hydroxyvitamin D3 (25OHD3). Incubation of macrophages with bacterial lipopolysaccharide (LPS) resulted in the conversion of [3H]25OHD3 to a more polar vitamin D3 metabolite (up to 15 pmol/10(6) cells). Untreated macrophages did not synthesize this metabolite. Several findings suggested that the metabolite was the biologically active form of vitamin D3, namely 1,25-dihydroxyvitamin D3 [1,25- (OH)2D3]. (1) The metabolite comigrated with chemically synthesized 1,25-(OH)2D3 on four different high performance liquid chromatographic systems. (2) The metabolite had the same affinity for the chick intestinal 1,25-(OH)2D3 receptor as authentic 1,25-(OH)2D3. (3) The biological activity of the macrophage metabolite in vivo (stimulation of intestinal calcium absorption and bone calcium mobilization in rachitic chicks) was identical to the activity of chemically synthesized 1,25-(OH)2D3. The LPS-stimulated synthesis of the 1,25- (OH)2D3-like compound by macrophages was dose dependent in a linear fashion; a half-maximal response was typically found with 100-200 ng LPS/10(6) cells. Polymyxin B abolished the effects of LPS on 25OHD3 metabolism in macrophages. Our data suggest that LPS-stimulated macrophages can modulate, on a local level, the function of 1,25- (OH)2D3-responsive cells by releasing the 1,25-(OH)2D3-like metabolite.
This article has been cited by other articles:
![]() |
D. Somjen, Y. Weisman, F. Kohen, B. Gayer, R. Limor, O. Sharon, N. Jaccard, E. Knoll, and N. Stern 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds Circulation, April 5, 2005; 111(13): 1666 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokomura, T. Suda, S. Sasaki, N. Inui, K. Chida, and H. Nakamura Increased Expression of the 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Gene in Alveolar Macrophages of Patients with Lung Cancer J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5704 - 5709. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fritsche, K. Mondal, A. Ehrnsperger, R. Andreesen, and M. Kreutz Regulation of 25-hydroxyvitamin D3-1{alpha}-hydroxylase and production of 1{alpha},25-dihydroxyvitamin D3 by human dendritic cells Blood, November 1, 2003; 102(9): 3314 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zehnder, R. Bland, R. S. Chana, D. C. Wheeler, A. J. Howie, M. C. Williams, P. M. Stewart, and M. Hewison Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines: A Novel Autocrine Determinant of Vascular Cell Adhesion J. Am. Soc. Nephrol., March 1, 2002; 13(3): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boonstra, F. J. Barrat, C. Crain, V. L. Heath, H. F. J. Savelkoul, and A. O'Garra 1{alpha},25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells J. Immunol., November 1, 2001; 167(9): 4974 - 4980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zehnder, R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 888 - 894. [Abstract] [Full Text] |
||||
![]() |
R. N. Auer Insulin, blood glucose levels, and ischemic brain damage Neurology, September 1, 1998; 51(3_Suppl_3): S39 - S43. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Nguyen, J. Pavlovitch, M. Papiernik, H. Guillozo, O. Walrant-Debray, C. Pontoux, and M. Garabedian Changes in 1,25-(OH)2D3 Synthesis and Its Receptor Expression in Spleen Cell Subpopulations of Mice Infected with LPBM5 Retrovirus Endocrinology, December 1, 1997; 138(12): 5505 - 5510. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uysal, L.E. Inan, and P. Kuli Vagal stimulation Neurology, November 1, 1996; 47(5): 1355 - 1356. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |